18th Annual BIO CEO & Investor Conference :: February 8-9, 2016 :: New York City :: Company Presentations & Educational Program Schedule
Key: = New IPO Since 1/1/2015 = Buzz of BIO Winner Phase of Development: = Discovery = Pre-Clinical = Phase I = Phase II = Phase III = NDA/In-Review = Multiple Products in Market = Not Applicable/Other = Patient Advocacy Group = Buzz of BIO Finalist #BIOCEO16 Monday, February 8th Duke of Windsor Park South Park North Conrad Louis XVI Jade & Astor 8:00 AM Altimmune, Inc. Arch Therapeutics, Inc. (OTCQB: ARTH) Capnia, Inc. (NASDAQ: CAPN) Infectious Diseases Galmed Pharmaceuticals (NASDAQ: GLMD) Cipher Pharmaceuticals (NASDAQ: CPHR) 8:15 AM Medical Devices Diagnostics Ziarco Group Ltd Gastrointestinal Dermatology Inflammation Improving Oncology Clinical Trials 8:30 AM ImCyse SA (Jade) Alcobra (NASDAQ: ADHD) Protea Biosciences Group, Inc. (OTCQB: PRGB) Platform for Therapeutics Synthetic Biologics, Inc. (NYSE MKT: SYN) Pluristem Therapeutics Inc. (NASDAQ: PSTI) 8:45 AM CNS/Neurological Tools/Drug Development Support Technology Aridis Pharmaceuticals Inc. Other Cardiovascular Infectious Diseases 9:00 AM Mariposa Health Inc Tonix Pharmaceuticals Holdings, Inc. (NASDAQ: TNXP) Aimmune Therapeutics (NASDAQ: AIMT) Respiratory Palatin Technologies, Inc. (NYSE MKT: PTN) Resverlogix Corp. (TSX: RVX) 9:15 AM CNS/Neurological Inflammation The Michael J Fox Foundation for Parkinson's Research Reproductive/Sexual Health Cardiovascular CNS/Neurological 9:30 AM ArmaGen, Inc. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) Axsome Therapeutics (NASDAQ: AXSM) CNS/Neurological Apricus Biosciences, Inc. (NASDAQ: APRI) Capricor (NASDAQ: CAPR) 9:45 AM Oncology CNS/Neurological Azevan Pharmaceuticals, Inc. Reproductive/Sexual Health Cardiovascular CNS/Neurological Advances in Ophthalmology 10:00 AM Hereditary Neuropathy Foundation (Jade) DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) Inovio Pharmaceuticals, Inc. (NASDAQ: INO) CNS/Neurological Prothena Corporation plc (NASDAQ: PRTA) RespireRx (OTCQB: RSPI) 10:15 AM Oncology Oncology AgeneBio, Inc. Multiple Therapeutics Respiratory CNS/Neurological 10:30 AM Highland Therapeutics Inc. OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED) Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) CNS/Neurological Galectin Therapeutics Inc (NASDAQ: GALT) Aradigm Corporation (NASDAQ: ARDM) 10:45 AM Oncology Oncology Accera Inc Multiple Therapeutics Respiratory CNS/Neurological 11:00 AM RaNA Therapeutics, Inc OncoSec Medical Incorporated (NASDAQ: ONCS) CytRx Corporation (NASDAQ: CYTR) Platform for Therapeutics BioSpecifics Technologies Corp. (NASDAQ: BSTC) Opexa Therapeutics (NASDAQ: OPXA) 11:15 AM Oncology Oncology Aurora BioPharma, Inc. Other Immunology Oncology 11:30 AM KPI Therapeutics Oxigene, Inc. (NASDAQ: OXGN) Galena Biopharma Inc. (NASDAQ: GALE) Immunology Akebia Therapeutics (NASDAQ: AKBA) Neovacs (EPA: ALNEV) 11:45 AM Oncology Oncology Targazyme, Inc. Multiple Therapeutics Immunology Immunology
12:00 PM Lunch - 12:55 PM Fireside Chat: U.S. Senator Charles E. Schumer 1:00 PM NeuroRx, Inc. Navidea Biopharmaceuticals, Inc. TG Therapeutics, Inc. (NASDAQ: TGTX) Oramed Pharmaceuticals (NASDAQ: ORMP) CNS/Neurological (NYSE MKT: NAVB) Oryzon Genomics (Madrid Exchange: ORY) (Astor) 1:15 PM Oncology Drug Delivery JDRF International Oncology Oncology Multiple Therapeutics 1:30 PM Sutro Biopharma Celator Pharmaceuticals, Inc (NASDAQ: CPXX) Bionik Laboratories (OTCQX: BNKL) Oncology Cytokinetics, Inc (NASDAQ: CYTK) Cerulean Pharma Inc. (NASDAQ: CERU) 1:45 PM Oncology CNS/Neurological Atreca, Inc. Orphan/Rare Diseases Oncology Fireside Chat: Dale Schenk, PhD Oncology CEO, Prothena 2:00 PM Batavia N.V. ImmunoCellular Therapeutics, Ltd (NYSE MKT: IMUC) Bionomics Ltd (ASX: BNO, OTCQX: BNOEF) Tools/Drug Development Support Technology Mast Therapeutics, Inc. (NYSE MKT: MSTX) Athersys, Inc. (NASDAQ: ATHX) (Astor) 2:15 PM Oncology CNS/Neurological Progenra Inc Orphan/Rare Diseases Regenerative Medicine Oncology 2:30 PM OticPharma, Ltd. Delcath Systems, Inc. (NASDAQ: DCTH) StemCells, Inc. (NASDAQ: STEM) Other Horizon Pharma plc (NASDAQ: HZNP) BioLineRx (NASDAQ: BLRX, TASE: BLRX) 2:45 PM Oncology CNS/Neurological GrayBug, Inc Orphan/Rare Diseases Oncology Ophthalmology 3:00 PM Ocugen, Inc. Provectus Biopharmaceuticals, Inc (NYSE MKT: PVCT) Cerecor Inc. (NASDAQ: CERC) Ophthalmology GlycoMimetics (NASDAQ: GLYC) NephroGenex, Inc. (NASDAQ: NRX) Fireside Chat: Samuel Isaly 3:15 PM Oncology CNS/Neurological Tyrogenex, Inc. Orphan/Rare Diseases Metabolic Diseases Ophthalmology Managing Partner, 3:30 PM Milestone Pharmaceuticals Inc. OrbiMed Advisors Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Probiodrug AG (Euronext Amsterdam: PBD) Cardiovascular La Jolla Pharmaceutical Company (NASDAQ: LJPC) Relmada Therapeutics (OTCQB: RLMD) 3:45 PM Oncology CNS/Neurological The Leukemia & Lymphoma Society Orphan/Rare Diseases Pain Management (Astor) Oncology 4:00 PM Viramal Limited Abeona Therapeutics, Inc (NASDAQ: ABEO) Onconova Therapeutics, Inc. (NASDAQ: ONTX) Reproductive/Sexual Health CytoSorbents Corporation (NASDAQ: CTSO) DURECT Corporation (NASDAQ: DRRX) 4:15 PM Gene/Cell Therapy Oncology Millendo Therapeutics Inc. Medical Devices Pain Management Orphan/Rare Diseases Addressing Alzheimer's Disease 4:30 PM Albireo Ltd. (Jade) Rexahn Pharmaceuticals (NYSE MKT: RNN) MEI Pharma, Inc. (NASDAQ: MEIP) Orphan/Rare Diseases Trevena Inc (NASDAQ: TRVN) PuriCore (LSE: PURI.L) 4:45 PM Oncology Oncology Opsona Therapeutics Ltd Multiple Therapeutics Inflammation Orphan/Rare Diseases 5:00 PM Bio-Path Holdings, Inc. (NASDAQ: BPTH) BioLife Solutions, Inc. (NASDAQ: BLFS) Addex Therapeutics Ltd (SWX: ADXN) Genocea Biosciences Inc (NASDAQ: GNCA) Proteon Therapeutics, Inc. (NASDAQ: PRTO) 5:15 PM Oncology Tools/Drug Development Support Technology CNS/Neurological Immunology Cardiovascular M&A in Overdrive 5:30 PM (Jade) NanoViricides, Incorporated (NYSE: NNVC) Curis, Inc. (NASDAQ: CRIS) Viking Therapeutics, Inc. (NASDAQ: VKTX) Immune Pharmaceuticals (NASDAQ: IMNP) Can-Fite BioPharma, Ltd. (NYSE MKT: CANF) 5:45 PM Infectious Diseases Oncology Metabolic Diseases Immunology Inflammation
6:00–7:00 PM Welcome Reception in Empire Room, sponsored by Janney Montgomery Scott 18th Annual BIO CEO & Investor Conference :: February 8-9, 2016 :: New York City :: Company Presentations & Educational Program Schedule
Key: = New IPO Since 1/1/2015 = Buzz of BIO Winner Phase of Development: = Discovery = Pre-Clinical = Phase I = Phase II = Phase III = NDA/In-Review = Multiple Products in Market = Not Applicable/Other = Patient Advocacy Group = Buzz of BIO Finalist #BIOCEO16 Tuesday, February 9th Duke of Windsor Park South Park North Conrad Louis XVI Jade & Astor 8:00 AM Harvard Apparatus Regenerative Technology, Inc. ERYTECH Pharma (EPA: ERYP) Verastem, Inc. (NASDAQ: VSTM) Biocept, Inc. (NASDAQ: BIOC) Catalyst Biosciences, Inc. (NASDAQ: CBIO) (NASDAQ: HART) 8:15 AM Oncology Oncology Diagnostics Orphan/Rare Diseases Regenerative Medicine Policy Outlook - PDUFA VI and You 8:30 AM Corbus Pharmaceuticals Holdings, Inc. (Jade) SciClone Pharmaceuticals Inc (NASDAQ: SCLN) Argos Therapeutics, Inc. (NASDAQ: ARGS) OncoCyte (NYSE: OCX) (NASDAQ: CRBP) SteadyMed Therapeutics (NASDAQ: STDY) 8:45 AM Oncology Oncology Diagnostics Orphan/Rare Diseases Drug Delivery
9:00 AM Minerva Biotechnologies Corporation Adaptimmune Therapeutics plc (NASDAQ: ADPT) AVEO Oncology (NASDAQ: AVEO) Oncology Newron Pharmaceuticals SpA (SWX: NWRN) ContraFect Corporation (NASDAQ: CFRX) 9:15 AM Oncology Oncology Nimbus Therapeutics LLC Orphan/Rare Diseases Infectious Diseases Metabolic Diseases 9:30 AM Izun Pharmaceuticals Selvita S.A. (WSE: SLV) Visiomed Group SA (Alternext: ALVMG) Multiple Therapeutics Catalyst Pharmaceuticals (NASDAQ: CPRX) Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) 9:45 AM Oncology Medical Devices KineMed, Inc Orphan/Rare Diseases Infectious Diseases Fireside Chat: George Scangos, PhD Multiple Therapeutics CEO, Biogen 10:00 AM Synlogic Biothera Pharmaceuticals Inc. Sophiris (NASDAQ: SPHS) Metabolic Diseases Ocera Therapeutics, Inc (NASDAQ: OCRX) Nicox (EPA: COX) (Astor) 10:15 AM Oncology Oncology Rebiotix Inc Orphan/Rare Diseases Ophthalmology Gastrointestinal 10:30 AM Bigfoot Biomedical MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) Oncolytics Biotech (OTCQX: ONCYF, TSX: ONC) Digital Health ProMetic Life Sciences (TSX: PLI, OTCQX: PFSCF) Nemus Bioscience, Inc. (OTCQB: NMUS) 10:45 AM Oncology Oncology Mitotech S.A. Orphan/Rare Diseases Ophthalmology Ophthalmology Understanding the Total Value of 11:00 AM Provista Diagnostics, Inc Innovative Therapies Mirna Therapeutics Inc. (NASDAQ: MIRN) CEL-SCI Corporation (NYSE MKT: CVM) Diagnostics Summit Therapeutics (NASDAQ: SMMT) pSivida Corp. (NASDAQ: PSDV) 11:15 AM Oncology Oncology Phagelux, Inc. Orphan/Rare Diseases Ophthalmology (Jade) Platform for Therapeutics 11:30 AM Cooperative Human Tissue Network (CHTN) Caladrius Biosciences, Inc. (NASDAQ: CLBS) Vascular Biogenics (NASDAQ: VBLT) Other BioBlast Pharma Ltd. (NASDAQ: ORPN) ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) 11:45 AM Other Oncology Symic Biomedical, Inc. Orphan/Rare Diseases Ophthalmology Multiline Global Biopharma Fireside Chat: Christi Shaw US Head, President, Novartis 12:00 PM Lunch - 12:55 PM Corporation (Astor) 1:00 PM EnGeneIC Ltd. ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) Relypsa, Inc. (NASDAQ: RLYP) Oncology AcelRx Pharmaceuticals (NASDAQ: ACRX) VBI Vaccines Inc. (NASDAQ: VBIV) 1:15 PM Oncology Metabolic Diseases Xcovery, Holding Company CNS/Neurological Immunology CRISPR/Cas9: Excitement and Oncology Concern for First Therapies 1:30 PM G1 Therapeutics Inc. Oasmia Pharmaceutical AB Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) CymaBay Therapeutics, Inc. (NASDAQ: CBAY) Oncology Anavex Life Sciences Corp. (NASDAQ: AVXL) (NASDAQ: OASM, FWB: OMAX.GR) (Jade) 1:45 PM Oncology Metabolic Diseases Helomics Corporation CNS/Neurological Oncology Oncology 2:00 PM BeyondSpring Pharmaceuticals, Inc. Diffusion Pharmaceuticals Inc. (OTCQX: DFFN) BioTime (NYSE: BTX) Oncology vTv Therapeutics (NASDAQ: VTVT) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH, TSX: AUP) Fireside Chat: John F. Milligan, PhD 2:15 PM Oncology Regenerative Medicine New York Stem Cell Foundation CNS/Neurological Immunology Platform for Therapeutics President and COO, 2:30 PM Bell Biosystems, Inc. Gilead Sciences Calithera Biosciences (NASDAQ: CALA) Zafgen (NASDAQ: ZFGN) Regenerative Medicine CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) RXi Pharmaceuticals Corporation (NASDAQ: RXII) 2:45 PM Other Metabolic Diseases NovaHep AB CNS/Neurological Dermatology (Astor) Regenerative Medicine 3:00 PM Nanobiotix (Euronext: NANO) Orexigen Therapeutics, Inc. (NASDAQ: OREX) Conatus Pharmaceuticals Inc. (NASDAQGM: CNAT) Alkermes (NASDAQ: ALKS) Alnylam Pharmaceuticals (NASDAQ: ALNY) Digital Health Spotlight: 3:15 PM Oncology Metabolic Diseases Gastrointestinal CNS/Neurological Orphan/Rare Diseases Building Continuous 3:30 PM Relationships with Patients OncBioMune Pharmaceuticals INC (OTCQB: OBMP) Histogenics Corporation (NASDAQ: HSGX) Tobira Therapeutics, Inc (NASDAQ: TBRA) Chembio Diagnostics. Inc. (NASDAQ: CEMI) Aethlon Medical, Inc. (NASDAQ: AEMD) 3:45 PM Oncology Regenerative Medicine Gastrointestinal Diagnostics Medical Devices (Jade)
4:00 PM RedHill Biopharma Ltd Egalet Corporation (NASDAQ: EGLT) Asterias (NYSE: AST) (NASDAQ: RDHL, TASE: RDHL) PDL BioPharma, Inc. (NASDAQ: PDLI) Stemline Therapeutics (NASDAQ: STML) 4:15 PM Pain Management Regenerative Medicine Gastrointestinal Other Oncology
4:30 PM Market Outlook - Post-Peak Adjustments -5:25 PM (Astor)
5:30–6:30 PM Closing Reception in Jade